Custom oligo, gene synthesis and NGS reagent manufacturer for genomics research
Integrated DNA Technologies manufactures synthetic nucleic acids and sequencing products, and its stack pairs factory automation (Beckhoff TwinCAT, EtherCAT, CMMS, LIMS) with a cloud bioinformatics layer (AWS EKS, Kubernetes, Nextflow, Polars). Hiring is accelerating and weighted toward sales and manufacturing, while a Finance Integration Lead role and dual ERP footprint (SAP, Dynamics 365) point to ongoing systems consolidation.
Notable leadership hires: Site Director, Finance Integration Lead
Integrated DNA Technologies, founded in 1987 and headquartered in Coralville, Iowa, produces custom oligonucleotides, primers, genes and gene fragments, RNA and DNA synthesis products, and next-generation sequencing reagents. It serves researchers and global health partners and operates GMP manufacturing. IDT is part of Danaher and employs 1,001–5,000 people. Hiring spans the United States, France, Belgium and Canada across sales, manufacturing, operations, support, engineering, finance and quality.
IDT runs SAP, Dynamics 365, Workday, Salesforce and OneStream for business systems, AWS EKS, Kubernetes, Terraform and PostgreSQL for infrastructure, and Nextflow, Python and Illumina tooling for genomics data.
IDT is headquartered in Coralville, Iowa, and hires in the United States, France, Belgium and Canada.
Job posts point to oligonucleotide synthesis workflow development, smart manufacturing, AI-enabled planning capabilities, operational integration planning and EH&S sustainability strategy.
Other companies in the same industry, closest in size
Integrated DNA Technologies's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.